<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;(1) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). (2) Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement.&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Registered Nurses' Association of Ontario (RNAO). Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2010 Feb. 27 p.  [84 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Registered Nurses' Association of Ontario (RNAO). Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Mar. 136 p.  [227 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Acute respiratory failure  (518.81); Breathing exercise  (93.18); Chronic airway obstruction, not elsewhere classified  (496); Cough  (786.2); Edema  (782.3); Shortness of breath  (786.05)"/><FieldValue Value="MSH: Adrenal Cortex Hormones ; Analgesics, Opioid ; Anti-Bacterial Agents ; Auscultation ; Breathing Exercises ; Bronchodilator Agents ; Cough ; Diagnostic Techniques, Respiratory System ; Drug Therapy, Combination ; Dyspnea ; Edema ; Exercise Therapy ; Health Policy ; Influenza Vaccines ; Mass Screening ; Metered Dose Inhalers ; Narcotics ; Nebulizers and Vaporizers ; Nicotine ; Nursing ; Nursing Care ; Nutrition Therapy ; Organizational Policy ; Oximetry ; Oxygen Inhalation Therapy ; Patient Care Planning ; Patient Education as Topic ; Pneumococcal Vaccines ; Psychotropic Drugs ; Pulmonary Disease, Chronic Obstructive ; Quality of Life ; Referral and Consultation ; Rehabilitation ; Relaxation ; Relaxation Therapy ; Respiration, Artificial ; Respiratory Insufficiency ; Respiratory Therapy ; Respiratory Tract Infections ; Self Care ; Smoking ; Smoking Cessation ; Spirometry ; Sputum ; Terminal Care ; Ventilators, Mechanical ; Vital Signs "/><FieldValue Value="MTH: Acute respiratory failure ; Adrenal Cortex Hormones ; Analgesics, Opioid ; Anti-Bacterial Agents ; Antibiotics ; Auscultation ; Breathing Exercises ; Care given by nurses ; Cessation of smoking ; Chronic airway obstruction, NEC in ICD9CM_2014 ; Chronic Obstructive Airway Disease ; Combination Drug Therapy ; Coughing ; Discipline of Nursing ; Dyspnea ; edema ; Influenza virus vaccine ; Inhaler ; Mechanical Ventilator ; Metered Dose Inhaler ; Narcotics ; Nicotine ; Nutrition management ; Nutrition Therapy ; Oxygen saturation measurement ; Oxygen Therapy Care ; Patient education (procedure) ; Physical therapy exercises ; Pneumococcal vaccine ; Pulmonary rehabilitation (procedure) ; Quality of life ; Rehabilitation therapy ; Relaxation ; Respiratory Insufficiency ; Respiratory Therapy ; Self-care interventions ; Smoking ; Spirometer (device) ; Sputum ; terminal patient care ; Vital signs "/><FieldValue Value="PDQ: nicotine "/><FieldValue Value="SNOMEDCT_US: Acute respiratory failure  (65710008); Antibacterial agent  (346325008); Antibacterial agent  (419241000); Antibiotic  (255631004); Artificial respiration  (40617009); Auscultation  (129436005); Auscultation  (37931006); Bronchodilator  (353866001); Bronchodilator  (372580007); Chronic obstructive pulmonary disease finding  (13645005); Chronic obstructive pulmonary disease finding  (413846005); Clearance of secretions of respiratory tract  (427391006); Corticoid preparation  (21568003); Corticoid preparation  (79440004); Cough  (263731006); Cough  (272039006); Cough  (49727002); Dying care  (182964004); Dying care  (385736008); Dyspnea  (230145002); Dyspnea  (267036007); Edema  (20741006); Edema  (267038008); Edema  (423666004); Edema  (79654002); Influenza virus vaccine  (396425006); Influenza virus vaccine  (46233009); Inhaler  (334980009); Inhaler  (420317006); Mechanical ventilator  (449071006); Metered dose inhaler  (422059006); Nicotine  (323283001); Nicotine  (373462006); Nicotine  (68540007); Nursing occupation  (265937000); Nutrition management  (386372009); Nutrition therapy  (386373004); Oxygen saturation measurement  (104847001); Oxygen saturation measurement  (264598005); Oxygen therapy  (57485005); Patient education  (311401005); Physiotherapeutic breathing exercise  (12895002); Pneumococcal vaccine  (333598008); Pneumococcal vaccine  (398730001); Psychotherapeutic agent  (418183005); Psychotherapeutic agent  (419937006); Psychotherapeutic agent  (46063005); Pulmonary rehabilitation  (15081005); Pulse oximeter  (448703006); Pulse oximetry  (252465000); Pulse oximetry  (708065004); Rehabilitation therapy  (52052004); Relaxation technique  (284467003); Relaxation training therapy  (64299003); Respiratory insufficiency  (409623005); Respiratory therapy  (53950000); Respiratory tract infection  (275498002); Self-care interventions  (384758001); Spirometer  (303501006); Spirometry  (127783003); Sputum  (45710003); Therapeutic exercise  (226029000); Therapeutic exercise  (229065009); Therapeutic exercise  (51998003); Vital signs  (46680005)"/><FieldValue Value="UMD: Inhalers, Aerosol  (12-128); Oximeters, Pulse  (17-148); Spirometers  (13-674)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Dyspnea associated with chronic obstructive pulmonary disease (COPD)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;COPD&lt;/li&gt;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Screening" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Internal Medicine" /><FieldValue Value="Nursing" /><FieldValue Value="Pulmonary Medicine" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Nurses" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To update the March 2005 Nursing Best Practice Guidelines for Nursing Care of Dyspnea: the 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) based on new evidence obtained since the originally published guidelines &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To address the nursing assessment and management of stable, unstable and acute dyspnea associated with COPD &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Patients with dyspnea associated with chronic obstructive pulmonary disease (COPD)&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Adults with dyspnea who have a history of smoking and who are over the age of 40&lt;/li&gt;&lt;/ul&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Evaluation/Screening&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Respiratory assessment, including vital signs, pulse oximetry, and chest auscultation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Identification of stable and unstable dyspnea, and acute respiratory failure &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for chronic obstructive pulmonary disease (COPD) in adults over 40 who have a history of smoking &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Advocating for spirometry testing in at-risk individuals &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Management/Treatment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Implementation of appropriate nursing interventions, including medications, controlled oxygen therapy, ventilation modalities, and strategies for secretion clearance, energy conserving, relaxation, nutrition, and breathing retraining &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Remaining with patient during episodes of acute respiratory distress &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Implementation of smoking cessation strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Administration of the following pharmacological agents as prescribed: bronchodilators, oxygen, corticosteroids, combination treatments, antibiotics, psychotropics, opioids &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of inhaler technique and coaching, if required &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Discussion of medications with patients &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Recommendation of annual influenza vaccination and pneumococcal vaccine (COPD patients) as appropriate &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Administration of oxygen therapy as prescribed &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Support of disease self-management strategies including action plan development &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Promotion of exercise training and pulmonary rehabilitation as appropriate &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Working collaboratively to ensure the highest quality of life possible for the person experiencing dyspnea at the end-of-life &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Patient education and referrals, if necessary &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Organization and policy strategies and programs/services to facilitate implementation &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul type=&quot;disc&quot;&gt;&#xD;&#xA;&lt;li&gt;Validity and reliability of dyspnea assessment tools&lt;/li&gt;&#xD;&#xA;&lt;li&gt;Effectiveness of intervention strategies at optimizing self-management of chronic obstructive pulmonary disease (COPD), reducing signs and symptoms of dyspnea, improving dyspnea scores, promoting comfort, improving quality of life and functional health status&lt;/li&gt;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Hand-searches of Published Literature (Primary Sources)" /><FieldValue Value="Searches of Electronic Databases" /><FieldValue Value="Searches of Unpublished Data" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;March 2005 Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A database search for existing chronic obstructive pulmonary disease guidelines was conducted by a university health sciences library. An initial search of the Medline, EMBASE, and CINAHL databases for guidelines and articles published from January 1, 1995 to December 2003 was conducted using the following search terms: &quot;chronic obstructive pulmonary disease,&quot; &quot;COPD,&quot; &quot;chronic obstructive lung disease,&quot; &quot;COLD,&quot; &quot;chronic bronchitis,&quot; &quot;emphysema,&quot; &quot;family caregivers,&quot; &quot;coping with chronic illness,&quot; &quot;oxygen devices,&quot; &quot;rehabilitation,&quot; &quot;assessing control,&quot; &quot;medications,&quot; &quot;randomized controlled trials,&quot; &quot;systematic reviews,&quot; &quot;practice guideline(s),&quot; &quot;clinical practice guideline(s),&quot; &quot;standards,&quot; &quot;consensus statement(s),&quot; &quot;consensus,&quot; &quot;evidence based guidelines,&quot; and &quot;best practice guidelines.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;One individual searched an established list of websites for content related to the topic area. This list of sites, reviewed and updated in October 2002, was compiled based on existing knowledge of evidence-based practice websites, known guideline developers, and recommendations from the literature. Presence or absence of guidelines was noted for each site searched as well as date searched. The websites at times did not house a guideline but directed to another website or source for guideline retrieval. Guidelines were either downloaded if full versions were available or were ordered by phone/e-mail.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A website search for existing chronic obstructive pulmonary disease guidelines was conducted via the search engine &quot;Google,&quot; using the search terms identified above. One individual conducted this search, noting the results of the search term results, the websites reviewed, date, and a summary of the findings. The search results were further critiqued by a second individual who identified guidelines and literature not previously retrieved.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Additionally, panel members were already in possession of a few of the identified guidelines. In some instances, a guideline was identified by panel members and not found through the previous search strategies. These were guidelines that were developed by local groups or specific professional associations and had not been published to date.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;This above search method revealed 13 guidelines, several systematic reviews, and numerous articles related to chronic obstructive pulmonary disease.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The final step in determining whether the clinical practice guideline would be critically appraised was to have two individuals screen the guidelines based on the following criteria. These criteria were determined by panel consensus:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Guideline was in English, international in scope. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guideline dated no earlier than 1997. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guideline was strictly about the topic area. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guideline was evidence-based (e.g., contained references, description of evidence, sources of evidence). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Guideline was available and accessible for retrieval. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Nine guidelines met the screening criteria and were critically appraised using the Appraisal of Guidelines for Research and Evaluation (AGREE Collaboration, 2001) instrument.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2010 Supplement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Literature Review&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;One individual searched an established list of websites for guidelines and other relevant content. This list was compiled based on existing knowledge of evidence-based practice websites and recommendations from the literature. Members of the panel critically appraised ten international guidelines, published since 2004, using the AGREE instrument (AGREE Collaboration, 2001). From this review, eight guidelines were identified to inform the review process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Concurrent with the review of existing guidelines, a search for recent literature relevant to the scope of the guideline was conducted with guidance from the Team Leader. The search of electronic databases (Medline, CINAHL and EMBASE) was conducted by a health sciences librarian. A Research Assistant (Master's prepared nurse) completed the inclusion/exclusion review, quality appraisal and data extraction of the retrieved studies, and prepared a summary of literature findings. The comprehensive data tables and reference lists were provided to all panel members.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A summary of the review process is provided in the Review Process Flow Chart in the original guideline document.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;2010 Supplement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A review of the new evidence yielded 867 abstracts and 10 guidelines; 76 articles and 8 guidelines were included and retrieved for review.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Ia&lt;/strong&gt; Evidence obtained from meta-analysis or systematic review of randomized controlled trials.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;Ib&lt;/strong&gt; Evidence obtained from at least one randomized controlled trial.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;IIa&lt;/strong&gt; Evidence obtained from at least one well-designed controlled study without randomization.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;IIb&lt;/strong&gt; Evidence obtained from at least one other type of well-designed quasi-experimental study, without randomization.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;III&lt;/strong&gt; Evidence obtained from well-designed non-experimental descriptive studies, such as comparative studies, correlation studies, and case studies.&lt;/p&gt;&#xA;&lt;p&gt;&lt;strong&gt;IV&lt;/strong&gt; Evidence obtained from expert committee reports or opinions and/or clinical experiences of respected authorities.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Review of Published Meta-Analyses" /><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;March 2005 Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In January of 2004, a panel of nurses with expertise in practice, education, and research related to chronic obstructive pulmonary disease was established by the Registered Nurses' Association of Ontario (RNAO). At the onset, the panel discussed and came to consensus on the scope of the best practice guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The panel members divided into subgroups to undergo specific activities using the short-listed guidelines, other literature, and additional resources for the purpose of drafting recommendations for nursing interventions. This process yielded a draft set of recommendations. The panel members as a whole reviewed the recommendations, discussed gaps, available evidence, and came to a consensus on a draft guideline.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;2010 Supplement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Registered Nurses' Association of Ontario (RNAO) has made a commitment to ensure that this practice guideline is based on the best available evidence. In order to meet this commitment, a monitoring and revision process has been established for each guideline every three years.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;A panel of nurses was assembled for this review, comprised of members from the original development panel as well as other recommended individuals with particular expertise in this practice area. A structured evidence review based on the scope of the original guideline and supported by three clinical questions was conducted to capture the relevant literature and guidelines published since the original publication in 2005.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Initial findings regarding the impact of the current evidence, based on the original recommendations, were summarized and circulated to the review panel. The revision panel members were given a mandate to review the original guideline in light of the new evidence, specifically to ensure the validity, appropriateness and safety of the guideline recommendation as published in 2005.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In September 2009, the panel was convened to achieve consensus on the need to revise the existing set of recommendations. A review of the most recent literature and relevant guidelines published since January 1, 2004 does not support dramatic changes to the recommendations, but rather suggest some refinements and stronger evidence for the approach.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Published cost analyses were reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The draft guideline (March 2005) was submitted to a set of external stakeholders for review and feedback of the content. It was also critiqued using the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument. An acknowledgement of these reviewers is provided at the front of the original guideline document. Stakeholders represented healthcare consumers, various healthcare disciplines, as well as a professional association. External stakeholders were provided with specific questions for comment, as well as the opportunity to give overall feedback and general impressions. The results were compiled and reviewed by the development panel. Discussion and consensus resulted in revision to the draft document prior to publication.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;em&gt;Note from the National Guideline Clearinghouse (NGC) and the Registered Nurses' Association of Ontario (RNAO)&lt;/em&gt;&lt;/strong&gt;: In September 2009, the panel was convened to achieve consensus on the need to revise the existing set of recommendations. A review of the most recent literature and relevant guidelines published since January 1, 2004 does not support dramatic changes to the recommendations, but rather suggest some refinements and stronger evidence for the approach.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The levels of evidence supporting the recommendations (Ia, Ib, IIa, IIb, III, IV) are defined at the end of the &quot;Major Recommendations&quot; field. See the original guideline document for additional information provided in the &quot;Discussion of Evidence.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Practice Recommendations&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Assessment&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 1.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will acknowledge and accept the patients' self-report of dyspnea.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 1.1 (updated 2010)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All individuals identified as having dyspnea related to chronic obstructive pulmonary disease (COPD) will be assessed appropriately. Respiratory assessment should include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Level of dyspnea&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Present level of dyspnea (for patients who are able to self-report): Present dyspnea should be measured using a quantitative scale such as a visual analogue or numeric rating scale &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Present level of dyspnea (for patients who are unable to self-report): Present level of dyspnea should be measured using a quantitative scale such as the Respiratory Distress Observation Scale (RDOS) &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Usual level of dyspnea&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Usual dyspnea should be measured using a quantitative scale such as the Medical Research Council (MRC) Dyspnea Scale. &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vital signs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pulse oximetry &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chest auscultation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chest wall movement and shape/abnormalities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Presence of peripheral edema &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Accessory muscle use &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Presence of cough and/or sputum &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ability to complete a full sentence &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Level of consciousness &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Watch for swallowing difficulties &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The recommendation has changed for the assessment of present level of dyspnea to differentiate between patients who are able to self-report and patients unable to self-report and the type of measurement scale to be used. An additional assessment parameter, swallowing assessment, has been added.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 1.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will be able to identify stable and unstable dyspnea and acute respiratory failure.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 1.3&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Every adult with dyspnea who has a history of smoking and is over the age of 40 should be screened to identify those most likely to be affected by COPD. As part of the basic dyspnea assessment, nurses should ask every patient:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Do you have progressive activity-related shortness of breath? &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Do you have a persistent cough and sputum production? &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Do you experience frequent respiratory tract infections? &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 1.4&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For patients who have a history of smoking and are over the age of 40, nurses should advocate for spirometric testing to establish early diagnosis in at risk individuals.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;COPD Dyspnea Interventions/Education&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 2.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will be able to implement appropriate nursing interventions for all levels of dyspnea including acute episodes of respiratory distress:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Acknowledgement and acceptance of patients' self-report of present level of dyspnea &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Medications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Controlled oxygen therapy &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Secretion clearance strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Non-invasive and invasive ventilation modalities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Energy conserving strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Relaxation techniques &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nutritional strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Breathing retraining strategies &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 2.1&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses must remain with patients during episodes of acute respiratory distress.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 2.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Smoking cessation strategies should be instituted for patients who smoke:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Refer to the Registered Nurses' Association of Ontario (RNAO) guideline &quot;Integrating Smoking Cessation into Daily Nursing Practice.&quot; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Use of nicotine replacement and other smoking cessation modalities during hospitalization for acute exacerbation &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Medications&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 3.0 (updated 2010)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses should provide appropriate administration of the following pharmacological agents as prescribed:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Bronchodilators (&lt;em&gt;Level of Evidence = 1b&lt;/em&gt;)&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Beta 2 agonists &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Anticholinergics &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Methylxanthines &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Oxygen (&lt;em&gt;Level of Evidence = 1b&lt;/em&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Corticosteroids (&lt;em&gt;Level of Evidence = 1b&lt;/em&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Combination treatments &lt;em&gt;(Level of Evidence = Ia)&lt;/em&gt; &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antibiotics (&lt;em&gt;Level of Evidence = 1a&lt;/em&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Psychotropics (&lt;em&gt;Level of Evidence = IV&lt;/em&gt;) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Opioids (&lt;em&gt;Level of Evidence = IV&lt;/em&gt;) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The discussion of evidence for this recommendation has been revised to reflect additional literature support and an additional paragraph under Corticosteroids which addresses Inhaled/IV corticosteroids. A new section on Combination Treatments has been added to the discussion of evidence in the original guideline document.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 3.1&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will assess patients' inhaler device technique to ensure accurate use. Nurses will coach patients with sub-optimal technique in proper inhaler/device technique.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = Ia)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 3.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will be able to discuss the main categories of medications with their patients including:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Trade and generic names &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Indications &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Doses &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Side effects &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Mode of administration &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Pharmacokinetics &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nursing considerations &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Vaccination&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 3.3&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Annual influenza vaccination should be recommended for individuals who do not have a contraindication.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 3.4&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;COPD patients should receive a pneumococcal vaccine at least once in their lives (high risk patients every 5 to 10 years).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Oxygen Therapy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 4.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses will assess for hypoxemia/hypoxia and administer appropriate oxygen therapy for individuals for all levels of dyspnea.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Disease Self-Management&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 5.0 (updated 2010)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses should support disease self-management strategies including:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Action plan development (&lt;em&gt;Level of Evidence = 1b&lt;/em&gt;)&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Awareness of baseline symptoms and activity level &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Recognition of factors that worsen symptoms &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Early symptom recognition of acute exacerbation/infection &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The above recommendation has had the last bullet point: End-of-life decision making/advanced directives (Level of Evidence = IV) removed.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 5.1&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses should promote exercise training.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 5.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses should promote pulmonary rehabilitation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Education Recommendations&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 6.0 (updated 2010)&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses working with patients with advanced illness causing dyspnea and their families will have the appropriate knowledge and skills to:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Encourage and promote ongoing dialogue regarding patient values, desired outcomes and treatment options &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ameliorate dyspnea and other distressing physical, emotional, social and spiritual symptoms using appropriate integrative and pharmacological approaches &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Work collaboratively with an inter-professional team to ensure the highest quality of life possible for the person experiencing dyspnea at the end-of-life. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: The above recommendation and discussion of evidence are new.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 7.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nurses working with individuals with dyspnea related to COPD will have the appropriate knowledge and skills to:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Recognize the importance of individual's self report of dyspnea &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Provide COPD patient education including:&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Smoking cessation strategies &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Pulmonary rehabilitation/exercise training &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Secretion clearance strategies &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Breathing retraining strategies &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Energy conserving strategies &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Relaxation techniques &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Nutritional strategies &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Role/rationale for oxygen therapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Role/rationale for medications &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Inhaler device techniques &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Disease self-management and action plans &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;End-of-life issues &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Conduct appropriate referrals to physician and community resources &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Organization Recommendations&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations must institutionalize dyspnea as the 6th vital sign.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.1&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations need to have in place COPD educators to teach both nurses and patients.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations need to ensure that a critical mass of health professionals are educated and supported to implement the guideline in order to ensure sustainability.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.3&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations will ensure sufficient nursing staff to provide essential care, safety and support for individuals with all levels of dyspnea.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.4&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations should have available sample medication delivery devices, spacer devices, sample templates of action plans, visual analogue scales, numeric rating scales, Medical Research Council (MRC) scales and patient education materials.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.5&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations need to have in place best practice guideline specific strategies to facilitate implementation. Organizations may wish to develop a plan for implementation that includes:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A process for the assessment of the patient population (e.g., numbers, clinical diagnostic practices, co-morbidities, average length of stay) of individuals usually cared for in their institution that are living with dyspnea related to COPD. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A process for the assessment of documentation practices related to the monitoring of dyspnea (usual and present dyspnea and dyspnea related therapies (e.g., pulse oximeter oxygen saturation [SPO&lt;sub&gt;2&lt;/sub&gt;]). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A process for the evaluation of the changes in the patient population and documentation strategies pre- and post-implementation. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;A process for the assessment of policies supporting the care of individuals living with dyspnea related to COPD. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.6&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations need to develop specific pre-implementation and outcome markers to monitor the impact of the implementation of this best practice guideline on the care of individuals with dyspnea related to COPD. Organizations may wish to evaluate:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Nursing knowledge base pre- and post-implementation. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Length of time between acute exacerbations of COPD (AECOPD) for specific individuals (perhaps globally represented by the number of acute care admissions and/or use of acute care resources over time pre- and post-implementation). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Development of documentation strategies to monitor and enhance care of individuals living with dyspnea related to COPD (integration of usual and present dyspnea on vital sign records within the institution). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Development of policies institutionalizing an education program for nurses caring for individuals living with dyspnea related to COPD. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 8.7&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nursing best practice guidelines can be successfully implemented only where there are adequate planning, resources, organizational and administrative support. Organizations may wish to develop a plan for implementation that includes:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;An assessment of organizational readiness and barriers to education &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Involvement of all members (whether in a direct or indirect supportive function) who will contribute to the implementation process &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Dedication of a qualified individual to provide the support needed for the education and implementation process &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Ongoing opportunities for discussion and education to reinforce the importance of best practices &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Opportunities for reflection on personal and organizational experience in implementing guidelines &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;In this regard, RNAO (through a panel of nurses, researchers and administrators) has developed the Toolkit: Implementation of Clinical Practice Guidelines, based on available evidence, theoretical perspectives and consensus. The RNAO strongly recommends the use of this Toolkit for guiding the implementation of the best practice guideline on Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Programs/Services Recommendations&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 9.0&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Pulmonary rehabilitation programs must be available for individuals with COPD to enhance quality of life and reduce health care costs.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = Ia)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 9.1&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Palliative care services must be available for individuals and their carers living with COPD.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = III)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 9.2&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Nursing research related to interventions for individuals with COPD must be supported.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 9.3&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;All nursing programs should include dyspnea associated with COPD as one context for learning core curricula concepts.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation 9.4&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Funding regulations for oxygen therapy must be revisited to include those individuals with severe dyspnea, reduced ventilatory capacity, and reduced exercise tolerance who do not qualify under the current criteria.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;(Level of Evidence = IV)&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Ia&lt;/strong&gt; Evidence obtained from meta-analysis or systematic review of randomized controlled trials.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Ib&lt;/strong&gt; Evidence obtained from at least one randomized controlled trial.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;IIa&lt;/strong&gt; Evidence obtained from at least one well-designed controlled study without randomization.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;IIb&lt;/strong&gt; Evidence obtained from at least one other type of well-designed quasi-experimental study, without randomization.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;III&lt;/strong&gt; Evidence obtained from well-designed non-experimental descriptive studies, such as comparative studies, correlation studies, and case studies.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;IV&lt;/strong&gt; Evidence obtained from expert committee reports or opinions and/or clinical experiences of respected authorities.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A chronic obstructive pulmonary disease (COPD) decision tree is provided in the original guideline document.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see &quot;Major Recommendations&quot;).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Appropriate assessment and management of patients with dyspnea associated with chronic obstructive pulmonary disease &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Symptom relief &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Optimization of patient self-management of chronic obstructive pulmonary disease (COPD) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Improved patient comfort, quality of life, and functional health status &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nurses, other health care professionals and administrators who are leading and facilitating practice changes will find this document valuable for the development of policies, procedures, protocols, educational programs, assessments, and documentation tools.&lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adverse effects of pharmacological agents. Common side effects are listed in Appendix L in the original guideline document, with updated information included in the 2010 supplement.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="430" OrdBy="800" Name="Contraindications"><Field FieldID="144" OrdBy="805" ID="431" Name="Contraindications" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Currently available evidence does not support the clinical use of nebulized opioids; however, some clinicians utilize opioids to treat the symptom of dyspnea in end-stage chronic obstructive pulmonary disease (COPD). Opioid use is contraindicated in COPD management due to the potential respiratory depression and worsening hypercapnia. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Tiotropium bromide is contraindicated in patients with hypersensitivity to atropine or its derivatives or lactose monohydrate. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Influenza vaccine is contraindicated in patients with egg allergy or thimerosal sensitivity. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;This nursing best practice guideline is a comprehensive document providing resources necessary for the support of evidence-based nursing practice. The document needs to be reviewed and applied, based on the specific needs of the organization or practice setting/environment, as well as the needs and wishes of the client. Guidelines should not be applied in a &quot;cookbook&quot; fashion but used as a tool to assist in decision making for individualized client care, as well as ensuring that appropriate structures and supports are in place to provide the best possible care. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Nurses, other healthcare professionals and administrators who are leading and facilitating practice changes will find this document valuable for the development of policies, procedures, protocols, educational programs, assessments and documentation tools. It is recommended that the nursing best practice guidelines be used as a resource tool. Nurses providing direct client care will benefit from reviewing the recommendations, the evidence in support of the recommendations and the process that was used to develop the guidelines. However, it is highly recommended that practice settings/environments adapt these guidelines in formats that would be user-friendly for daily use. This guideline has some suggested formats for such local adaptation and tailoring. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;These best practice guidelines are related only to nursing practice and not intended to take into account fiscal efficiencies. These guidelines are not binding for nurses and their use should be flexible to accommodate client/family wishes and local circumstances. They neither constitute a liability nor discharge from liability. While every effort has been made to ensure the accuracy of the contents at the time of publication, neither the authors nor the Registered Nurses' Association of Ontario (RNAO) give any guarantee as to the accuracy of the information contained in them, nor accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceutical products as examples does not imply endorsement of any of these products. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;It is acknowledged that individual competencies of nurses vary between nurses and across categories of nursing professionals (registered nurses [RNs] and registered practical nurses [RPNs]) and are based on knowledge, skills, attitudes and judgement enhanced over time by experience and education. It is expected that individual nurses will perform only those aspects of care for which they have received appropriate education and experience. Both RNs and RPNs should seek consultation in instances where the patient's care needs surpass the individual nurse's ability to act independently. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Although this guideline contains recommendations for RNs and RPNs, caring for individuals with chronic obstructive pulmonary disease is an interdisciplinary endeavour. It is acknowledged that effective care depends on a coordinated interdisciplinary approach incorporating ongoing communication between health professionals and patients. Personal preferences and unique needs as well as the personal and environmental resources of each individual patient must always be kept in mind. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Similar to the original guideline publication, the supplement needs to be reviewed and applied, based on the specific needs of the organization or practice setting/environment, as well as the needs and wishes of the client. This supplement should be used in conjunction with the original guideline: Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD) (RNAO, 2005) as a tool to assist in decision-making for individualized client care, as well as ensuring that appropriate structures and supports are in place. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Best practice guidelines can only be successfully implemented if there are adequate planning, resources, organizational and administrative support as well as appropriate facilitation. Registered Nurses' Association of Ontario (RNAO), through a panel of nurses, researchers and administrators has developed the &lt;em&gt;Toolkit: Implementation of Clinical Practice Guidelines&lt;/em&gt; based on available evidence, theoretical perspectives and consensus. The Toolkit is recommended for guiding the implementation of any clinical practice guideline in a health care organization.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Toolkit provides step-by-step directions to individuals and groups involved in planning, coordinating, and facilitating the guideline implementation. Specifically, the Toolkit addresses the following key steps in implementing a guideline:&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Identifying a well-developed, evidence-based clinical practice guideline &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Identification, assessment and engagement of stakeholders &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Assessment of environmental readiness for guideline implementation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Identifying and planning evidence-based implementation strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Planning and implementing evaluation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Identifying and securing required resources for implementation &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;Implementing guidelines in practice that result in successful practice changes and positive clinical impact is a complex undertaking. The Toolkit is one key resource for managing this process.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Evaluation and Monitoring&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Organizations implementing the recommendations in this nursing best practice guideline are encouraged to consider how the implementation and its impact will be monitored and evaluated. A table found in the original guideline document, based on a framework outlined in the Registered Nurses' Association of Ontario Toolkit: Implementation of Clinical Practice Guidelines (2002), illustrates some indicators for monitoring and evaluation.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Implementation Strategies&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The Registered Nurses' Association of Ontario and the guideline development panel have compiled a list of implementation strategies to assist health care organizations or health care disciplines who are interested in implementing this guideline. See the original guideline document for a summary of strategies.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Audit Criteria/Indicators" /><FieldValue Value="Chart Documentation/Checklists/Forms" /><FieldValue Value="Clinical Algorithm" /><FieldValue Value="Foreign Language Translations" /><FieldValue Value="Mobile Device Resources" /><FieldValue Value="Patient Resources" /><FieldValue Value="Quick Reference Guides/Physician Guides" /><FieldValue Value="Resources" /><FieldValue Value="Slide Presentation" /><FieldValue Value="Tool Kits" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="End of Life Care" /><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Registered Nurses' Association of Ontario (RNAO). Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD) 2010 supplement. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2010 Feb. 27 p.  [84 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Registered Nurses' Association of Ontario (RNAO). Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Mar. 136 p.  [227 references]&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2005 Mar (addendum released Feb 2010)" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Registered Nurses' Association of Ontario - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Funding was provided by the Ontario Ministry of Health and Long Term Care.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Guideline Development Panel&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Revision Panel Members&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Pat Hill Bailey, RN, PhD &lt;br /&gt;&#xD;&#xA;&lt;strong&gt;Team Leader&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;Professor&lt;br /&gt;&#xD;&#xA;Laurentian University&lt;br /&gt;&#xD;&#xA;School of Nursing&lt;br /&gt;&#xD;&#xA;Sudbury, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Ann Bartlett, RN, BScN, MSc, CRE,&lt;br /&gt;&#xD;&#xA;NARTC/Diploma in COPD&lt;br /&gt;&#xD;&#xA;Nurse Clinician&lt;br /&gt;&#xD;&#xA;Firestone Institute for Respiratory Health&lt;br /&gt;&#xD;&#xA;St. Joseph's Healthcare&lt;br /&gt;&#xD;&#xA;Hamilton, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Julie Duff Cloutier, RN BScN, MSc&lt;br /&gt;&#xD;&#xA;Assistant Professor&lt;br /&gt;&#xD;&#xA;Laurentian University&lt;br /&gt;&#xD;&#xA;School of Nursing&lt;br /&gt;&#xD;&#xA;Sudbury, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Donna Goodridge, RN, PhD, CHPCN(c)&lt;br /&gt;&#xD;&#xA;Associate Professor&lt;br /&gt;&#xD;&#xA;College of Nursing&lt;br /&gt;&#xD;&#xA;University of Saskatchewan&lt;br /&gt;&#xD;&#xA;Saskatoon, Saskatchewan&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Meeran Manji, RN&lt;br /&gt;&#xD;&#xA;COPD Educator&lt;br /&gt;&#xD;&#xA;Pulmonary Rehabilitation Program&lt;br /&gt;&#xD;&#xA;University Health Network-&lt;br /&gt;&#xD;&#xA;Toronto Western Hospital&lt;br /&gt;&#xD;&#xA;Toronto, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Christina McMillan Boyles, RN, BScN, MScN&lt;br /&gt;&#xD;&#xA;Lecturer&lt;br /&gt;&#xD;&#xA;Laurentian University&lt;br /&gt;&#xD;&#xA;School of Nursing&lt;br /&gt;&#xD;&#xA;Sudbury, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Brenda Dusek, RN, BN, MN&lt;br /&gt;&#xD;&#xA;Program Manager&lt;br /&gt;&#xD;&#xA;International Affairs and Best Practice Guidelines Program&lt;br /&gt;&#xD;&#xA;Registered Nurses' Association of Ontario&lt;br /&gt;&#xD;&#xA;Toronto, Ontario&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Glynis Vales, BA&lt;br /&gt;&#xD;&#xA;Program Assistant&lt;br /&gt;&#xD;&#xA;International Affairs and Best Practice Guidelines Program&lt;br /&gt;&#xD;&#xA;Registered Nurses' Association of Ontario&lt;br /&gt;&#xD;&#xA;Toronto, Ontario&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Declarations of interest and confidentiality were made by all members of the guideline development panel. Further details are available from the Registered Nurses' Association of Ontario.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available in English and Spanish in Portable Document Format (PDF) from the &lt;a href=&quot;http://rnao.ca/bpg/guidelines/nursing-care-dyspneathe-6th-vital-sign-individuals-chronic-obstructive-pulmonary-dise&quot; title=&quot;RNAO Web site&quot;&gt;Registered Nurses' Association of Ontario (RNAO) Web site&lt;/a&gt;.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from Registered Nurses' Association of Ontario (RNAO), Nursing Best Practice Guidelines Project, 158 Pearl Street, Toronto, Ontario M5H 1L3 &lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Summary of recommendations. Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2010. 5 p. Electronic copies: Available in Portable Document Format (PDF) from the &lt;a href=&quot;http://rnao.ca/sites/rnao-ca/files/storage/related/605_BPG_COPD_summary.pdf&quot; title=&quot;RNAO Web site&quot;&gt;Registered Nurses Association of Ontario (RNAO) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Chart of medications. Revised Appendix L. Nursing care of dyspnea: the 6th vital sign in individuals with chronic obstructive pulmonary disease (COPD). Registered Nurses' Association of Ontario (RNAO); 2010 Feb. 7 p. Electronic copies: Available in PDF from the &lt;a href=&quot;http://rnao.ca/sites/rnao-ca/files/storage/related/6136_COPD_Supp_AppL_FA.pdf&quot; title=&quot;RNAO Web site&quot;&gt;RNAO Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Toolkit: implementation of clinical practice guidelines. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2002 Mar. 88 p. Electronic copies: Available in PDF from the &lt;a href=&quot;http://rnao.ca/bpg/resources/toolkit-implementation-clinical-practice-guidelines&quot; title=&quot;RNAO Web site&quot;&gt;RNAO Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Sustainability of best practice guideline implementation. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2006. 24 p. Electronic copies: Available in PDF and as a Power Point presentation from the &lt;a href=&quot;http://rnao.ca/bpg/guidelines/resources/sustainability-best-practice-guideline-implementation&quot; title=&quot;RNAO Web site&quot;&gt;RNAO Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Educator's resource: integration of best practice guidelines. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Jun. 123 p. Electronic copies: Available in PDF from the &lt;a href=&quot;http://rnao.ca/bpg/guidelines/resources/educators-resource-integration-best-practice-guidelines&quot; title=&quot;RNAO Web site&quot;&gt;RNAO Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Print copies: Available from the Registered Nurses' Association of Ontario (RNAO), Nursing Best Practice Guidelines Project, 158 Pearl Street, Toronto, Ontario M5H 1L3&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Various resources, including measures of clinical dyspnea, a sample assessment form, and breathing and relaxation techniques are included in the appendices of the &lt;a href=&quot;http://rnao.ca/sites/rnao-ca/files/Nursing_Care_of_Dyspnea_-The_6th_Vital_Sign_in_Individuals_with_Chronic_Obstructive_Pulmonary_Disease.pdf&quot; title=&quot;RNAO Web site&quot;&gt;original guideline document&lt;/a&gt;. Indicators for monitoring and evaluation are also available in a table.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Mobile versions of RNAO guidelines are available from the &lt;a href=&quot;http://pda.rnao.ca/guideline-content/20&quot; title=&quot;RNAO Web siie&quot;&gt;RNAO Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Health education fact sheet. Chronic obstructive pulmonary disease (COPD) &amp;ndash; helping you breathe easier. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Dec. 2p. Electronic copies: Available in English and Italian in Portable Document Format (PDF) from the &lt;a href=&quot;http://rnao.ca/bpg/fact-sheets/chronic-obstructive-pulmonary-disease-copd-%E2%80%93-helping-you-breathe-better&quot; title=&quot;RNAO Web site&quot;&gt;Registered Nurses' Association of Ontario (RNAO) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This summary was completed by ECRI on June 3, 2005. The updated information was verified by the guideline developer on June 21, 2005. This summary was updated by ECRI Institute on July 8, 2011. The updated information was verified by the guideline developer on August 9, 2011.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;With the exception of those portions of this document for which a specific prohibition or limitation against copying appears, the balance of this document may be produced, reproduced, and published in its entirety only, in any form, including in electronic form, for educational or non-commercial purposes, without requiring the consent or permission of the Registered Nurses' Association of Ontario, provided that an appropriate credit or citation appears in the copied work as follows:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Registered Nurses' Association of Ontario 2010. Nursing Care of Dyspnea: The 6th Vital Sign in Individuals with Chronic Obstructive Pulmonary Disease (COPD). Toronto, Canada: Registered Nurses' Association of Ontario.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
